Eddy Agbo is a prominent biotech entrepreneur with extensive experience in global health innovation. He is the CEO and Chairman of Fyodor Biotechnologies, Inc., a company that is transforming global healthcare delivery by bringing lab tests to patients. Agbo holds multiple degrees, including a PhD in Molecular Genetics from Utrecht University, and a DVM in Veterinary Medicine from the University of Ibadan. He also completed a post-doctoral fellowship in Medicine and Infectious Diseases at Johns Hopkins University School of Medicine. Agbo's more recent studies include Leadership and Management in the Life Sciences, Biotechnology at The Johns Hopkins University - Carey Business School.

Agbo is passionate about using his skills for the greater good. His company, Fyodor Biotechnologies, has commercialized the first and only non-blood dipstick test that can detect malaria within minutes using urine. The Urine Malaria Test (UMT) is being used to save lives at scale in places where transportation and traditional lab testing is difficult. Before starting Fyodor, Agbo worked as a Research Fellow at Johns Hopkins University School of Medicine and as the Senior Director of Research and Development at Cangen Biotechnologies Corp. Now, as CEO of Fyodor, Agbo is leading a team of innovators who are making a significant impact on global health.